GO:1903909 regulation of receptor clustering: Signaling Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903909 (regulation of receptor clustering) is a biological process that modulates the frequency, rate, or extent of receptor clustering, a key event in signal transduction.
• Receptor clustering is essential for many signaling pathways, including TNF receptor superfamily signaling, innate immune responses, and apoptosis.
• Clustering can be ligand-dependent or ligand-independent, and it modulates transmembrane signaling.
• Dysregulation of receptor clustering is implicated in diseases such as cancer, immune disorders, and clustering epilepsy.
• Key genes involved include TNFRSF members, TLRs, death receptors, and nuclear hormone receptors.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are powerful tools to study the regulation of receptor clustering.
Description
Receptor clustering is a fundamental process in cell signaling, where receptors assemble into higher-order structures on the cell membrane to initiate or modulate downstream signaling. The regulation of this clustering, defined by GO:1903909, encompasses any process that controls the frequency, rate, or extent of receptor clustering. This regulation is critical for diverse biological functions, from immune responses to apoptosis and hormone signaling. Understanding how receptor clustering is regulated provides insights into both normal physiology and disease mechanisms, such as cancer and neurological disorders. Researchers study this process using advanced imaging, biochemical assays, and genetic models to dissect the molecular players and signaling outcomes.
regulation of receptor clustering At A Glance
| GO ID | GO:1903909 |
|---|---|
| GO term | regulation of receptor clustering |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate, or extent of receptor clustering |
| Related processes | Signal transduction, immune response, apoptosis |
| Key regulators | Scaffold proteins, kinases, phosphatases, lipids |
| Disease relevance | Cancer, immune disorders, epilepsy |
What Is GO:1903909?
GO:1903909, regulation of receptor clustering, is defined as any process that modulates the frequency, rate or extent of receptor clustering. In other words, it includes all molecular events that control how often, how quickly, or how extensively receptors come together into clusters on the cell surface or within membranes. This regulation can involve changes in receptor conformation, interactions with scaffold proteins, lipid composition, or post-translational modifications.
Why Is regulation of receptor clustering Important in Cell Biology?
Regulation of receptor clustering is crucial because clustering often serves as a switch that turns on or amplifies signaling pathways. For example, clustering of TNF receptors enhances signaling efficiency, while clustering of innate immune receptors is essential for detecting pathogens. Dysregulated clustering can lead to excessive or insufficient signaling, contributing to diseases such as cancer, autoimmunity, and neurodegeneration. Thus, understanding the regulation of receptor clustering offers potential therapeutic targets and biomarkers.
• Controls signal transduction efficiency and specificity.
• Essential for immune receptor activation and pathogen detection.
• Modulates apoptosis through death receptor clustering.
• Influences hormone-responsive gene expression via nuclear receptor clustering.
• Implicated in cancer progression and metastasis.
• Linked to neurological disorders such as clustering epilepsy.
• Provides targets for therapeutic intervention.
• Key to understanding ligand-independent signaling mechanisms.
• Involved in Wnt signaling and developmental processes.
• Offers opportunities for CRISPR-based functional studies.
What Happens During regulation of receptor clustering?
Initiation of Receptor Clustering
In simple terms: Receptors start to gather together on the cell surface.
Receptor clustering can be initiated by ligand binding, which induces conformational changes that promote receptor-receptor interactions. For some receptors, clustering occurs in a ligand-independent manner, driven by intrinsic properties or membrane microdomains. This step is regulated by factors such as receptor density, affinity, and the presence of scaffolding proteins.
Amplification and Stabilization of Clusters
In simple terms: Once started, clusters grow and become more stable.
After initiation, clusters are amplified through positive feedback mechanisms involving adaptor proteins and kinases. For example, in TNF receptor signaling, clustering leads to recruitment of TRAFs and activation of downstream pathways. Stabilization often requires interactions with the cytoskeleton or lipid rafts.
Modulation by Post-translational Modifications
In simple terms: Chemical tags on receptors can change how they cluster.
Phosphorylation, ubiquitination, and other modifications regulate receptor clustering by altering receptor conformation or interactions. For instance, phosphorylation of death receptors can enhance or inhibit clustering. These modifications are controlled by kinases and phosphatases that act as regulators of clustering.
Termination and Dispersal of Clusters
In simple terms: Clusters can break apart to stop signaling.
Receptor clusters are dynamic and can be dispersed by internalization, degradation, or active disruption. Regulation of cluster dispersal is important for signal termination and prevention of chronic activation. Mechanisms include endocytosis, dephosphorylation, and action of inhibitory proteins.
Key Genes Involved in GO:1903909 regulation of receptor clustering
The following genes and proteins are key players in the regulation of receptor clustering, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TNFRSF1A | TNF receptor superfamily member; clustering enhances signaling | Studied in inflammation and cancer |
| TLR4 | Innate immune receptor; clustering required for pathogen detection | Model for immune regulation |
| FAS | Death receptor; clustering triggers apoptosis | Target for cancer therapy |
| PGR | Progesterone receptor; clustering modulates transcriptional activity | Breast cancer research |
| DAAM2 | Scaffold protein; couples Wnt receptor clustering | Developmental signaling |
| RAC1 | Small GTPase; regulates receptor clustering | Cytoskeleton dynamics |
| ESR2 | Estrogen receptor beta; influences miRNA biogenesis | Hormone-responsive cancers |
| NHR | Nuclear hormone receptors; implicated in clustering epilepsy | Neurological disorders |
| TRAF2 | Adaptor protein; mediates TNF receptor clustering | Inflammation and apoptosis |
| MYD88 | Adaptor in TLR signaling; affects clustering | Innate immunity |
| CASP8 | Caspase; activated by death receptor clustering | Apoptosis research |
| ERK | Kinase; modulates progesterone receptor clustering | Cell signaling |
| WNT5A | Ligand; induces Wnt receptor clustering | Cancer and development |
| GAB1 | Scaffold; involved in receptor tyrosine kinase clustering | Signal transduction |
| SRC | Kinase; phosphorylates receptors affecting clustering | Cancer signaling |
| PTPN11 | Phosphatase; regulates receptor clustering | Developmental disorders |
| ARRB1 | Arrestin; modulates receptor clustering and internalization | GPCR signaling |
| HSP90 | Chaperone; stabilizes receptors for clustering | Cancer and stress response |
How Is regulation of receptor clustering Regulated?
Regulation of receptor clustering is itself controlled by various cellular mechanisms. For example, ERK-mediated phosphorylation can modulate progesterone receptor clustering and transcriptional activity. Scaffold proteins such as DAAM2 and Rac1 regulate Wnt receptor clustering. Additionally, ligand-independent mechanisms and membrane lipid composition can influence clustering. These regulatory layers ensure that receptor clustering is tightly controlled in response to cellular needs.
regulation of receptor clustering and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ESR2 | Breast cancer | Knockout in breast cancer cell lines |
| NHR | Clustering epilepsy | Knock-in mouse models |
| FAS | Apoptosis-related diseases | Point mutation in death domain |
| TLR4 | Immune disorders | Overexpression in macrophages |
| TNFRSF1A | Inflammation and cancer | Knockout in tumor models |
Cancer
Dysregulated receptor clustering is implicated in cancer. For instance, estrogen receptor beta regulates microRNA biogenesis in hormone-responsive breast cancer, affecting cell proliferation. Clustering of death receptors can influence apoptosis, and its modulation is a therapeutic strategy. TNF receptor clustering is linked to tumor progression and inflammation.
Neurological Disorders
Clustering epilepsy is associated with nuclear hormone receptor signaling, as revealed by multiomic analysis. Aberrant receptor clustering may contribute to neuronal hyperexcitability. Understanding these mechanisms could lead to new treatments.
Immune Disorders
Innate immune receptor clustering is essential for immune regulation; defects can lead to autoimmunity or immunodeficiency. TLR clustering abnormalities are linked to chronic inflammatory diseases.
From regulation of receptor clustering-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate receptor clustering? | Knockout cell line |
| How does a specific mutation affect clustering? | Point mutation knock-in |
| What is the effect of tagging the receptor? | Tagged knock-in |
| Does overexpression alter clustering dynamics? | Overexpression stable cell line |
| Which proteins interact with clustered receptors? | Proximity labeling or co-IP |
| Can we visualize clustering in live cells? | Fluorescently tagged receptor knock-in |
How to Study the regulation of receptor clustering Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Super-resolution microscopy | Cluster size and distribution | Visualizing receptor clustering |
| FRET/BRET | Receptor-receptor interactions | Detecting clustering in live cells |
| Co-immunoprecipitation | Protein complexes | Identifying cluster components |
| CRISPR knockout screen | Genes affecting clustering | Functional genomics |
| RNA-seq | Transcriptional changes | Downstream effects of clustering |
| Proteomics | Protein abundance and modifications | Cluster composition |
| Stochastic modeling | Kinetics of clustering | Predicting signaling dynamics |
Imaging Techniques
Advanced microscopy such as super-resolution and single-molecule imaging allows visualization of receptor clustering in real time. These methods quantify cluster size, density, and dynamics.
Biochemical Assays
Co-immunoprecipitation and crosslinking can detect receptor clusters and identify interacting partners. These assays help elucidate the molecular composition of clusters.
Genetic Screens
CRISPR-based screens can identify regulators of receptor clustering by knocking out candidate genes and assessing clustering phenotypes.
Computational Modeling
Stochastic models simulate receptor clustering and predict signaling outcomes, as shown for progesterone receptor.
How CRISPR Can Be Used to Study GO:1903909 regulation of receptor clustering
Knockout
CRISPR knockout of candidate genes can reveal their role in receptor clustering. For example, knocking out DAAM2 or RAC1 disrupts Wnt receptor clustering. Knockout models are essential for loss-of-function studies.
Point Mutation
Introducing specific point mutations (e.g., in phosphorylation sites) can dissect the regulation of clustering. Point mutations in death receptors affect apoptotic signaling.
Knock-in
Knock-in of tagged receptors (e.g., GFP) allows real-time imaging of clustering. This approach has been used to study receptor dynamics.
Overexpression
Overexpression of receptors or regulators can enhance clustering and amplify signaling, useful for gain-of-function studies.
How EDITGENE Supports regulation of receptor clustering Research
Researchers studying regulation of receptor clustering-related genes often need to determine whether a candidate gene is causally involved in clustering and downstream signaling. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for regulation of receptor clustering research.
Frequently Asked Questions About regulation of receptor clustering
What is GO:1903909?
GO:1903909 is the Gene Ontology term for regulation of receptor clustering, a biological process that modulates the frequency, rate, or extent of receptor clustering.
What genes are involved in regulation of receptor clustering?
Key genes include TNFRSF1A, TLR4, FAS, PGR, DAAM2, RAC1, ESR2, and NHR, among others.
Why is receptor clustering important?
It is crucial for signal transduction, immune responses, apoptosis, and hormone signaling; dysregulation leads to diseases like cancer and epilepsy.
How is receptor clustering regulated?
It is regulated by ligand binding, post-translational modifications, scaffold proteins, and kinases such as ERK.
What diseases are associated with abnormal receptor clustering?
Cancer, immune disorders, and clustering epilepsy are linked to dysregulated receptor clustering.
What methods study receptor clustering?
Super-resolution microscopy, FRET, co-IP, CRISPR screens, and computational modeling.
Can CRISPR be used to study receptor clustering?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used.
What is ligand-independent receptor clustering?
It is clustering that occurs without ligand binding, modulating transmembrane signaling.
How does ERK regulate progesterone receptor clustering?
ERK-mediated phosphorylation modulates progesterone receptor translocation, clustering, and transcriptional activity.
What is the role of DAAM2 in receptor clustering?
DAAM2 couples translocation and clustering of Wnt receptor signalosomes through Rac1.
Conclusion
Regulation of receptor clustering (GO:1903909) is a vital biological process that controls signal transduction across diverse pathways. Its dysregulation contributes to cancer, immune disorders, and neurological diseases. Understanding the molecular mechanisms and key genes involved offers opportunities for therapeutic intervention. CRISPR-based models and advanced imaging techniques are indispensable for dissecting this process, and EDITGENE provides the tools to accelerate such research.
References
- 1. Vanamee ÉS et al.. 2023. The benefits of clustering in TNF receptor superfamily signaling.. Front Immunol 14:1225704 PMID: 37662920
- 2. Li M et al.. 2021. Innate immune receptor clustering and its role in immune regulation.. J Cell Sci 134(4) PMID: 33597156
- 3. Wang Y et al.. 2021. Clustering of Death Receptor for Apoptosis Using Nanoscale Patterns of Peptides.. ACS Nano 15(6):9614-9626 PMID: 34019379
- 4. Marquez-Lago TT et al.. 2022. Stochastic model of ERK-mediated progesterone receptor translocation, clustering and transcriptional activity.. Sci Rep 12(1):11791 PMID: 35821038
- 5. Cristobal CD et al.. 2021. Daam2 couples translocation and clustering of Wnt receptor signalosomes through Rac1.. J Cell Sci 134(2) PMID: 33310913
- 6. Sánchez MF et al.. 2023. Ligand-independent receptor clustering modulates transmembrane signaling: a new paradigm.. Trends Biochem Sci 48(2):156-171 PMID: 36115755
- 7. Paris O et al.. 2012. Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer.. Oncogene 31(38):4196-206 PMID: 22231442
- 8. de Nys R et al.. 2024. Multiomic analysis implicates nuclear hormone receptor signalling in clustering epilepsy.. Transl Psychiatry 14(1):65 PMID: 38280856
